Thymidine phosphorylase. Substrate specificity for 5-substituted 2'-deoxyuridines. 1980

C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda

A continuous spectrophotometric assay for thymidine phosphorylase has been developed and used to analyze the substrate properties of a number of 5-substituted 2'-deoxyuridines. A QSAR was found which relates the catalytic efficiency for various substrates to a single variable, the inductive field constant F.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013939 Thymidine Phosphorylase An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine. PD-ECGF,Platelet-Derived Endothelial Cell Growth Factor,Gliostatin,Platelet Derived Endothelial Cell Growth Factor
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
December 1983, Biochemical pharmacology,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
January 2007, Biochemistry. Biokhimiia,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
July 1976, Journal of medicinal chemistry,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
January 1979, Voprosy virusologii,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
June 1964, The Journal of biological chemistry,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
May 1984, Chemical & pharmaceutical bulletin,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
October 1980, Methods and findings in experimental and clinical pharmacology,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
March 1981, Analytical biochemistry,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
November 1979, Biochemical pharmacology,
C Nakayama, and Y Wataya, and R B Meyer, and D V Santi, and M Saneyoshi, and T Ueda
June 1991, Journal of medicinal chemistry,
Copied contents to your clipboard!